EsoCap announces authorisation of capital increase by extraordinary general assembly and successful closing of its private placement offering

EsoCap AG announced that a capital increase has been authorized by the Extraordinary General Assembly, held on April 11, 2019, followed by successful completion of a private placement financing. The…

Continue Reading EsoCap announces authorisation of capital increase by extraordinary general assembly and successful closing of its private placement offering
EsoCap one of just a handful of companies selected to present at the Bio-Europe conference start up spotlight on March 26, 2019

EsoCap one of just a handful of companies selected to present at the Bio-Europe conference start up spotlight on March 26, 2019

EsoCap AG is one of just a handful of companies in the area of biotech and medtech selected to present at the Bio-Europe conference start-up spotlight on March 26th, 2019 in Vienna.

Continue Reading EsoCap one of just a handful of companies selected to present at the Bio-Europe conference start up spotlight on March 26, 2019

EsoCap holds a scientific advisory board meeting in eosinophilic esophagitis

EsoCap AG organized a scientific advisory board meeting with eight international experts in Eosinophilic Esophagitis (EoE) in Zürich on June 14th, 2018. Prof. Dr. Werner Weitschies, Head of the Center of Drug Absorption and Transport at the University of Greifswald gave a keynote presentation on EsoCap’s unique drug delivery platform.

Continue Reading EsoCap holds a scientific advisory board meeting in eosinophilic esophagitis

EsoCap announces issuance of patent in South Africa for its smart application technology in the upper gastrointestinal tract

EsoCap AG announced today that the South Africa Patent and Trademark Office has issued the Patent No.  2017/03831 on March 28th, 2018 which is directed at the smart application technology enabling specific site-directed treatments of several diseases of the esophagus.

Continue Reading EsoCap announces issuance of patent in South Africa for its smart application technology in the upper gastrointestinal tract